A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)
Clinical trial NCT05460325 · COMPLETED
Trial details
- NCT number
- NCT05460325
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-22
- Primary completion
- 2023-11-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.